| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.29 | 5e-20 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-10 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0003 |